Effects of human endothelial gene polymorphisms on cellular responses to hyperglycaemia: Role of NOS3 (Glu298Asp) and ACE (I/D) polymorphisms

Mandar S. Joshi; Suvara Wattanapitayakul; Brandon L. Schanbacher; John A. Bauer

doi:10.1177/1479164111416679

Effects of human endothelial gene polymorphisms on cellular responses to hyperglycaemia: Role of NOS3 (Glu298Asp) and ACE (I/D) polymorphisms

Mandar S. Joshi, Suvara Wattanapitayakul, Brandon L. Schanbacher, John A. Bauer

Pediatrics

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

The functional relevance of NOS3 and ACE genetic variations to endothelial cell function is largely unstudied. Here we tested the functional relevance of the NOS3 (Glu298Asp) polymorphism and ACE (I/D) polymorphism in endothelial cells in vitro. Our hypothesis was that these genetic polymorphisms alter endothelial cell sensitivity to glucose and 3-nitrotyrosine (3NT). Genotyped HUVECs were incubated with glucose, free 3NT or a combination of these two toxicants. Significant differences in glucose-induced cell death and free 3NT-induced cell death were observed among the NOS3 genotypes. Combined glucose/3NT caused increased toxicity among the NOS3 genotypes. No differences were observed among the ACE genotypes in their responses to glucose/3NT. These data demonstrate that the NOS3 genotype may be an important predictor of, or be mechanistically involved in, endothelial vulnerability, whereas the ACE I/D genotype is apparently less important. Thus this NOS3 genetic variation may play a role in vulnerability to endothelium-dependent diabetic vascular complications.

Original language	English
Pages (from-to)	276-283
Number of pages	8
Journal	Diabetes and Vascular Disease Research
Volume	8
Issue number	4
DOIs	https://doi.org/10.1177/1479164111416679
State	Published - Oct 2011

Bibliographical note

Funding Information:
This work was supported by the National Institutes of Health [Grant numbers HL63067 and DK55053; PI: JAB] and the Victorian Government’s Operational Infrastructure Support Program.

Keywords

angiotensin converting enzyme (ACE)
diabetes
endothelial nitric oxide synthase (NOS3)
genetic polymorphisms
vascular complications

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1177/1479164111416679

Cite this

@article{5eb93c23cdb7459fa079f6c7f6154ae1,

title = "Effects of human endothelial gene polymorphisms on cellular responses to hyperglycaemia: Role of NOS3 (Glu298Asp) and ACE (I/D) polymorphisms",

abstract = "The functional relevance of NOS3 and ACE genetic variations to endothelial cell function is largely unstudied. Here we tested the functional relevance of the NOS3 (Glu298Asp) polymorphism and ACE (I/D) polymorphism in endothelial cells in vitro. Our hypothesis was that these genetic polymorphisms alter endothelial cell sensitivity to glucose and 3-nitrotyrosine (3NT). Genotyped HUVECs were incubated with glucose, free 3NT or a combination of these two toxicants. Significant differences in glucose-induced cell death and free 3NT-induced cell death were observed among the NOS3 genotypes. Combined glucose/3NT caused increased toxicity among the NOS3 genotypes. No differences were observed among the ACE genotypes in their responses to glucose/3NT. These data demonstrate that the NOS3 genotype may be an important predictor of, or be mechanistically involved in, endothelial vulnerability, whereas the ACE I/D genotype is apparently less important. Thus this NOS3 genetic variation may play a role in vulnerability to endothelium-dependent diabetic vascular complications.",

keywords = "angiotensin converting enzyme (ACE), diabetes, endothelial nitric oxide synthase (NOS3), genetic polymorphisms, vascular complications",

author = "Joshi, {Mandar S.} and Suvara Wattanapitayakul and Schanbacher, {Brandon L.} and Bauer, {John A.}",

note = "Funding Information: This work was supported by the National Institutes of Health [Grant numbers HL63067 and DK55053; PI: JAB] and the Victorian Government{\textquoteright}s Operational Infrastructure Support Program. ",

year = "2011",

month = oct,

doi = "10.1177/1479164111416679",

language = "English",

volume = "8",

pages = "276--283",

number = "4",

}

TY - JOUR

T1 - Effects of human endothelial gene polymorphisms on cellular responses to hyperglycaemia

T2 - Role of NOS3 (Glu298Asp) and ACE (I/D) polymorphisms

AU - Joshi, Mandar S.

AU - Wattanapitayakul, Suvara

AU - Schanbacher, Brandon L.

AU - Bauer, John A.

N1 - Funding Information: This work was supported by the National Institutes of Health [Grant numbers HL63067 and DK55053; PI: JAB] and the Victorian Government’s Operational Infrastructure Support Program.

PY - 2011/10

Y1 - 2011/10

N2 - The functional relevance of NOS3 and ACE genetic variations to endothelial cell function is largely unstudied. Here we tested the functional relevance of the NOS3 (Glu298Asp) polymorphism and ACE (I/D) polymorphism in endothelial cells in vitro. Our hypothesis was that these genetic polymorphisms alter endothelial cell sensitivity to glucose and 3-nitrotyrosine (3NT). Genotyped HUVECs were incubated with glucose, free 3NT or a combination of these two toxicants. Significant differences in glucose-induced cell death and free 3NT-induced cell death were observed among the NOS3 genotypes. Combined glucose/3NT caused increased toxicity among the NOS3 genotypes. No differences were observed among the ACE genotypes in their responses to glucose/3NT. These data demonstrate that the NOS3 genotype may be an important predictor of, or be mechanistically involved in, endothelial vulnerability, whereas the ACE I/D genotype is apparently less important. Thus this NOS3 genetic variation may play a role in vulnerability to endothelium-dependent diabetic vascular complications.

AB - The functional relevance of NOS3 and ACE genetic variations to endothelial cell function is largely unstudied. Here we tested the functional relevance of the NOS3 (Glu298Asp) polymorphism and ACE (I/D) polymorphism in endothelial cells in vitro. Our hypothesis was that these genetic polymorphisms alter endothelial cell sensitivity to glucose and 3-nitrotyrosine (3NT). Genotyped HUVECs were incubated with glucose, free 3NT or a combination of these two toxicants. Significant differences in glucose-induced cell death and free 3NT-induced cell death were observed among the NOS3 genotypes. Combined glucose/3NT caused increased toxicity among the NOS3 genotypes. No differences were observed among the ACE genotypes in their responses to glucose/3NT. These data demonstrate that the NOS3 genotype may be an important predictor of, or be mechanistically involved in, endothelial vulnerability, whereas the ACE I/D genotype is apparently less important. Thus this NOS3 genetic variation may play a role in vulnerability to endothelium-dependent diabetic vascular complications.

KW - angiotensin converting enzyme (ACE)

KW - diabetes

KW - endothelial nitric oxide synthase (NOS3)

KW - genetic polymorphisms

KW - vascular complications

UR - http://www.scopus.com/inward/record.url?scp=80053058309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053058309&partnerID=8YFLogxK

U2 - 10.1177/1479164111416679

DO - 10.1177/1479164111416679

M3 - Article

C2 - 21844127

AN - SCOPUS:80053058309

SN - 1479-1641

VL - 8

SP - 276

EP - 283

JO - Diabetes and Vascular Disease Research

JF - Diabetes and Vascular Disease Research

IS - 4

ER -

Effects of human endothelial gene polymorphisms on cellular responses to hyperglycaemia: Role of NOS3 (Glu298Asp) and ACE (I/D) polymorphisms

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this